Merck's rotavirus vaccine approved by FDA

02/4/2006 | San Francisco Chronicle

The FDA approved Merck's RotaTeq vaccine against rotavirus, a virus that affects most young children and often is fatal in developing countries. In response to problems with an earlier vaccine, Merck and competitor GlaxoSmithKline conducted trials to ensure their vaccines do not cause dangerous obstructions of the intestine.

View Full Article in:

San Francisco Chronicle

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC